Explore evidence

44.4 odds_ratioAmong African females, pain behind the eyes had an odds ratio of 44.4 for acute HIV infection compared to uninfected participants.

Kenyahuman immunodeficiency virus infectionpublished 2022MedicinePubMeddocument of 12 observations

5 rankEmbu County was the 5th leading county in diabetes mellitus morbidity in Kenya in 2019.

Kenyadiabète (non précisé)observed 2019published 2021The Pan African medical journalPubMeddocument of 3 observations

42 patientsPatients from whom bacterial enteric pathogens were isolated and identified included 42 from Malindi County Referral Hospital.

Kenyabacterial enteric pathogenspublished 2019African Journal of Health SciencesOpenAlexdocument of 18 observations

34 %Approximately 34% of the 497 HIV-positive women disclosed their HIV-positive status to a sexual partner.

KenyaVIH/sidaobserved 2012published 2019Journal of HIV and AIDSeurope_pmcdocument of 2 observationsDOI 10.16966/2380-5536.166

63 %KSHV seroprevalence was 63% by age 2 years in Kenyan children assessed by multiplex assay.

Kenyasarcome de Kaposiobserved age 2 yearspublished 2021The Journal of infectious diseasesPubMeddocument of 2 observations

92.2 %Rapid diagnostic tests registered a sensitivity of 92.2% for Plasmodium falciparum infection in children.

Kenyapaludismeobserved 2014published 2019Wellcome open researcheurope_pmcdocument of 6 observations

9.8 %The prevalence of severe anaemia (haemoglobin < 7 g/dL) was 9.8% among all parities of 275 pregnant women attending the antenatal clinic at Kilifi district hospital, Kenya, in November 1993.

Kenyaanémieobserved November 1993published 1996Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 7 observations

4,232 casesThe Pneumonia Etiology Research for Child Health project enrolled 4232 cases of hospitalized WHO-defined severe and very severe pneumonia from 9 sites in 7 countries.

Kenyapneumoniepublished 2017Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 7 observations

39.8 scoreThe mean breast cancer stigma score was 39.8.

Kenyacancer du seinpublished 2025JCO global oncologyPubMeddocument of 5 observations

33.1 %The average relative survival from cervical cancer in the 11 countries was 33.1% at 5 years.

Kenyacancer du col de l'utérusobserved 2005 to 2015published 2020International journal of cancereurope_pmcdocument of 6 observations

1,000,000,000 US dollarsAlmost US$1 billion in international funding is distributed each year to the 1.4 billion people exposed to stable Plasmodium falciparum malaria risk.

Kenyapaludismepublished 2008PLoS medicineeurope_pmcdocument of 5 observations

Episodes of clinical malaria were recorded in a population from 2007 to 2017.

Kenyapaludismeobserved 2007 to 2017published 2025Malaria journalPubMeddocument of 8 observations

93 %Among 1,047,406 people reported with TB in Kenya between 2008 and 2018, 93% knew their HIV status.

Kenyatuberculose · VIH/sidaobserved 2008 to 2018published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations

76 %The monthly testing positivity rate (TPR) reduced from 46% in February 2016 to 11% in February 2018 in the intervention area, representing a 76% absolute decrease in TPR among all ages.

Kenyapaludismeobserved February 2016 to February 2018published 2022PloS onePubMeddocument of 6 observations

1.25 per_100_person-yearsHIV incidence was 1.25 per 100 person-years among women who declined PrEP.

KenyaVIH/sidapublished 2026PLoS medicinePubMeddocument of 10 observations

1,676 KShThe total household cost per patient admitted with a malaria diagnosis was KSh 1676 (USD 16.4).

Kenyapaludismeobserved June 2016 to May 2017published 2021Malaria journalPubMeddocument of 11 observations

69.3 relative_utilityClinically stable people living with HIV preferred receiving care at a health facility over home-delivery or a community meeting point, with relative utilities of 69.3, -16.2, and -53.1, respectively.

KenyaVIH/sidapublished 2021PloS onePubMeddocument of 6 observations

15.1 %Severe anaemia (Hb < 7 g/dl) was found among 15.1% of primigravidae in the intervention arm.

Kenyaanémiepublished 1998Tropical medicine & international health : TM & IHeurope_pmcdocument of 7 observations

89.3 %Fingerprint technology achieved a sensitivity of 89.3% for unique patient matching and identification in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

92.9 %Among virally suppressed AYPLHIV at baseline enrolled in Operation Triple Zero (OTZ), 92.9% of males sustained viral load suppression (VLS).

KenyaVIH/sidapublished 2025The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 9 observations

27 %Among 10,096 adolescents and young adults aged 10–24 years on antiretroviral treatment for more than 6 months in 99 HIV clinics in Kenya between January 2016 and December 2017, the proportion with unsuppressed viral load at last test was 27%.

KenyaVIH/sidaobserved 2016–2017published 2020AIDS (London, England)PubMeddocument of 3 observations

39 %Overall, service-based malaria vaccine coverage was 39% for dose 4 of RTS,S/AS01 in Kenya's pilot implementation.

Kenyapaludismeobserved 2019-2022published 2023Malaria journaleurope_pmcdocument of 10 observations

Malaria mortality showed spatial variation that peaked every May-June in western Kenya between 2008 and 2019.

Kenyapaludismeobserved 2008–2019published 2024BMJ global healthPubMeddocument of 8 observations

1.78 ORProstration was associated with uraemia with an odds ratio of 1.78.

Kenyauraemiapublished 2021Malaria journalPubMeddocument of 14 observations

The incidence of both uncomplicated and severe P. falciparum malaria was close to baseline in children heterozygous with respect to the mutation underlying the hemoglobin S variant and homozygous with respect to the mutation underlying alpha(+)-thalassemia.

Kenyapaludismepublished 2005Nature geneticseurope_pmcDOI 10.1038/ng1660